# OnCo record drd2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/drd2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "drd2" ;
  schema:name "Dopamine D2 receptor"@en ;
  schema:description "The dopamine D2 receptor is how cabergoline and bromocriptine shrink prolactin-secreting pituitary tumours without surgery, and it is the target of the antiemetics metoclopramide and prochlorperazine used during chemotherapy."@en ;
  schema:url <https://onco.cc/targets/drd2/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Dopamine_receptor_D2>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3023>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149295>, <https://www.uniprot.org/uniprotkb/P14416/entry>, <https://www.ncbi.nlm.nih.gov/gene/1813> ;
  schema:citation <https://www.uniprot.org/uniprotkb/P14416/entry>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3023>, <https://www.ebi.ac.uk/chembl/explore/target/CHEMBL217> ;
  onco:tag "chembl-gap" ;
  schema:alternateName "DRD2" ;
  onco:targetClass "other" ;
  onco:firstDescribed "1989"^^xsd:gYear ;
  onco:related <https://onco.cc/targets/sstr2/> ;
  onco:cancers <https://onco.cc/cancers/pituitary-tumours/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/dordaviprone/> .